High concordance of 70‐gene recurrence risk signature and 80‐gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early‐stage breast cancer

BACKGROUND AND OBJECTIVES: With increased neoadjuvant therapy recommendations for early‐stage breast cancer patients due to the COVID‐19 pandemic, it is imperative that molecular diagnostic assays provide reliable results from preoperative core needle biopsies (CNB). The study objective was to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Crozier, Jennifer A., Barone, Julie, Whitworth, Pat, Cheong, Abraham, Maganini, Robert, Tamayo, Jose Perez, Dauer, Patricia, Wang, Shiyu, Audeh, William, Glas, Annuska M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Breast
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305900/
https://www.ncbi.nlm.nih.gov/pubmed/34964996
http://dx.doi.org/10.1002/jso.26780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305900/
https://www.ncbi.nlm.nih.gov/pubmed/34964996
http://dx.doi.org/10.1002/jso.26780

Ejemplares similares